| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK1 DOCK2 IQSEC3 GRIPAP1 SWAP70 KALRN ARFGEF2 ARFGEF1 PLCD4 DENND4C ARFGEF3 ARHGEF9 SH3BP5 RGL4 | 3.26e-09 | 231 | 154 | 14 | GO:0005085 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 DOCK2 IQSEC3 ARL2BP GRIPAP1 SWAP70 KALRN LRRK2 ARFGEF2 ARFGEF1 PLCD4 DENND4C ARFGEF3 ARHGEF9 PLCB1 TBC1D21 EVI5L SH3BP5 RGL4 | 1.39e-08 | 507 | 154 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 DOCK2 IQSEC3 ARL2BP GRIPAP1 SWAP70 KALRN LRRK2 ARFGEF2 ARFGEF1 PLCD4 DENND4C ARFGEF3 ARHGEF9 PLCB1 TBC1D21 EVI5L SH3BP5 RGL4 | 1.39e-08 | 507 | 154 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.02e-07 | 18 | 154 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.18e-06 | 28 | 154 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.72e-06 | 118 | 154 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.13e-06 | 37 | 154 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.67e-05 | 70 | 154 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.19e-05 | 10 | 154 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAP2A LRRK2 ABCA7 TUBB1 ATP6V1H RHOBTB2 KIF28P ABCB11 DNM1 RAP2C DNAH5 DNAH8 DNAH9 ATP2B2 ATP2B3 MX2 DNAH11 | 1.04e-04 | 775 | 154 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.06e-04 | 97 | 154 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 1.76e-04 | 3 | 154 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 1.76e-04 | 3 | 154 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK1 DOCK2 IQSEC3 ARL2BP GRIPAP1 SWAP70 KALRN LRRK2 TOPBP1 ARFGEF2 ARFGEF1 PLCD4 CIT DENND4C FAF1 ARFGEF3 PPP4R3B ATP6V1H ARHGEF9 PLCB1 TBC1D21 EVI5L SH3BP5 RGL4 | 2.21e-04 | 1418 | 154 | 24 | GO:0030234 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAP2A LRRK2 ABCA7 TUBB1 ATP6V1H RHOBTB2 KIF28P ABCB11 DNM1 RAP2C DNAH5 DNAH8 DNAH9 ATP2B2 ATP2B3 MX2 DNAH11 | 2.66e-04 | 839 | 154 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAP2A LRRK2 ABCA7 TUBB1 ATP6V1H RHOBTB2 KIF28P ABCB11 DNM1 RAP2C DNAH5 DNAH8 DNAH9 ATP2B2 ATP2B3 MX2 DNAH11 | 2.70e-04 | 840 | 154 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAP2A LRRK2 ABCA7 TUBB1 ATP6V1H RHOBTB2 KIF28P ABCB11 DNM1 RAP2C DNAH5 DNAH8 DNAH9 ATP2B2 ATP2B3 MX2 DNAH11 | 2.70e-04 | 840 | 154 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | calmodulin binding | 4.24e-04 | 230 | 154 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.66e-04 | 20 | 154 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 6.22e-04 | 22 | 154 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 8.08e-04 | 24 | 154 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PDE1A PDE1B PLCD4 PPM1J PTPRG PTPRS PLCB1 PDE5A PLCL1 PTPN20 | 8.46e-04 | 386 | 154 | 10 | GO:0042578 |
| GeneOntologyMolecularFunction | small GTPase binding | DOCK1 DOCK2 TNPO2 LRRK2 UNC13D RAB11FIP1 CYFIP2 TBC1D21 EVI5L | 8.85e-04 | 321 | 154 | 9 | GO:0031267 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 9.13e-04 | 25 | 154 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G DNHD1 ACTC1 ABCA7 ATP6V1H KIF28P ABCB11 DNAH5 DNAH8 DNAH9 ATP2B2 ATP2B3 DNAH11 | 9.65e-04 | 614 | 154 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.03e-03 | 26 | 154 | 3 | GO:0004435 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.15e-03 | 27 | 154 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 1.42e-03 | 29 | 154 | 3 | GO:0004629 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.48e-03 | 279 | 154 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.57e-03 | 109 | 154 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.61e-03 | 8 | 154 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | GTPase binding | DOCK1 DOCK2 TNPO2 LRRK2 UNC13D RAB11FIP1 CYFIP2 TBC1D21 EVI5L | 1.95e-03 | 360 | 154 | 9 | GO:0051020 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 2.20e-03 | 439 | 154 | 10 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 2.20e-03 | 439 | 154 | 10 | GO:0019001 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA7 ATP6V1H KIF28P ABCB11 DNAH5 DNAH8 DNAH9 ATP2B2 ATP2B3 DNAH11 | 2.27e-03 | 441 | 154 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.61e-03 | 178 | 154 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 3.11e-03 | 11 | 154 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | GTP binding | 3.74e-03 | 397 | 154 | 9 | GO:0005525 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 1.49e-08 | 5 | 154 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | CCDC125 DOCK1 DOCK2 IQSEC3 RAP2A SWAP70 KALRN LRRK2 ARFGEF2 ARFGEF1 PLCD4 DENND4C ARFGEF3 RHOBTB2 ARHGEF9 RAP2C SCAI RGL4 | 1.17e-07 | 538 | 154 | 18 | GO:0007264 |
| GeneOntologyBiologicalProcess | extracellular transport | 6.84e-06 | 62 | 154 | 6 | GO:0006858 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 2.37e-05 | 23 | 154 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | postsynapse organization | DOCK1 IQSEC3 KALRN ACTBL2 SH3GL2 LRRK2 CYFIP2 PTPRS ARHGEF9 FAM9C DCLK1 | 2.42e-05 | 313 | 154 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | cilium movement | ADCY10 DNHD1 MNS1 STARD7 CATSPER2 DNAH5 TBC1D21 DNAH8 DNAH9 DNAH11 | 2.75e-05 | 261 | 154 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 2.83e-05 | 24 | 154 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | CCDC125 DOCK2 IQSEC3 SWAP70 KALRN ARFGEF2 ARFGEF1 DENND4C ARFGEF3 ARHGEF9 SCAI | 4.25e-05 | 333 | 154 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 7.86e-05 | 59 | 154 | 5 | GO:0003351 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 RAP2A KALRN SYNE1 ACTBL2 LRRK2 LAMB3 LAMC2 CIT CYFIP2 PTPRS BHLHE22 FAM9C ATP2B2 DCLK1 NIN | 1.55e-04 | 748 | 154 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | vesicle scission | 1.65e-04 | 3 | 154 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.85e-04 | 210 | 154 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | synapse organization | DOCK1 IQSEC3 GRIPAP1 RAP2A KALRN ACTBL2 SH3GL2 LRRK2 CYFIP2 LGI2 PTPRS ARHGEF9 FAM9C ATP2B2 DCLK1 | 1.95e-04 | 685 | 154 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 2.17e-04 | 215 | 154 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 2.17e-04 | 215 | 154 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 3.22e-04 | 44 | 154 | 4 | GO:0052652 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 RAP2A KALRN SYNE1 ACTBL2 SH3GL2 LRRK2 LAMB3 LAMC2 CIT CYFIP2 PTPRS BHLHE22 FAM9C DCLK1 NIN | 3.38e-04 | 802 | 154 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 DNHD1 MNS1 KTN1 STARD7 CATSPER2 KIF28P DNAH5 TBC1D21 DNAH8 DNAH9 DNAH11 | 3.39e-04 | 493 | 154 | 12 | GO:0007018 |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 3.51e-04 | 45 | 154 | 4 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cGMP metabolic process | 3.62e-04 | 19 | 154 | 3 | GO:0046068 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | DNHD1 PDE1A MNS1 TSGA10 CATSPER2 DNAH5 TBC1D21 DNAH8 DNAH9 DRC3 DNAH11 | 1.40e-06 | 238 | 152 | 11 | GO:0097729 |
| GeneOntologyCellularComponent | motile cilium | ADCY10 DNHD1 PDE1A MNS1 ACTA2 TSGA10 CATSPER2 DNAH5 TBC1D21 DNAH8 DNAH9 DRC3 DNAH11 | 2.06e-06 | 355 | 152 | 13 | GO:0031514 |
| GeneOntologyCellularComponent | supramolecular fiber | MNS1 IFFO1 SYNE1 ACTBL2 APC2 ACTA1 ACTA2 ARFGEF2 ACTC1 ACTG2 FSD1 LMNB2 RYR3 TUBB1 RTL1 KIF28P DNM1 DNAH5 DNAH8 DNAH9 PTPN20 MX2 DNAH11 NIN | 4.49e-06 | 1179 | 152 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MNS1 IFFO1 SYNE1 ACTBL2 APC2 ACTA1 ACTA2 ARFGEF2 ACTC1 ACTG2 FSD1 LMNB2 RYR3 TUBB1 RTL1 KIF28P DNM1 DNAH5 DNAH8 DNAH9 PTPN20 MX2 DNAH11 NIN | 5.04e-06 | 1187 | 152 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | cilium | ADCY10 DNHD1 ARL2BP PDE1A EVC2 MNS1 BEST2 ACTA2 TSGA10 ARFGEF2 CATSPER2 DNAH5 TBC1D21 DNAH8 DNAH9 ATP2B2 DRC3 DNAH11 NIN | 2.91e-05 | 898 | 152 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MNS1 IFFO1 ACTBL2 APC2 ACTA1 ARFGEF2 ACTC1 FSD1 LMNB2 TUBB1 KIF28P DNM1 DNAH5 DNAH8 DNAH9 PTPN20 MX2 DNAH11 NIN | 2.96e-05 | 899 | 152 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.02e-05 | 25 | 152 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule | MNS1 APC2 ARFGEF2 FSD1 TUBB1 KIF28P DNM1 DNAH5 DNAH8 DNAH9 PTPN20 MX2 DNAH11 NIN | 3.60e-05 | 533 | 152 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | dynein complex | 4.52e-05 | 54 | 152 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | outer dynein arm | 7.90e-05 | 12 | 152 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 8.25e-05 | 32 | 152 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 8.25e-05 | 32 | 152 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | axoneme | 1.40e-04 | 207 | 152 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.45e-04 | 208 | 152 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | sperm flagellum | 1.76e-04 | 214 | 152 | 8 | GO:0036126 | |
| GeneOntologyCellularComponent | recycling endosome | 2.26e-04 | 222 | 152 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | photoreceptor ribbon synapse | 2.84e-04 | 18 | 152 | 3 | GO:0098684 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1G FKBP15 SWAP70 KALRN ACTBL2 APC2 ACTA1 ACTA2 TOPBP1 ACTC1 ACTG2 CIT ZYX | 3.07e-04 | 576 | 152 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | laminin-5 complex | 3.12e-04 | 4 | 152 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | endosome | IL12A FKBP15 GRIPAP1 RAP2A SH3GL2 UBR4 LRRK2 ARFGEF2 UNC13D RAB11FIP1 ABCA7 EHD4 ATP6V1H ZFYVE9 RHOBTB2 ABCB11 TOLLIP AP1G2 ZFYVE26 RAP2C | 3.13e-04 | 1167 | 152 | 20 | GO:0005768 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.17e-04 | 45 | 152 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GRIPAP1 RAP2A MOSPD2 SEC24A SH3GL2 UBR4 LRRK2 RAB11FIP1 ABCA7 DENND4C EHD4 STAB1 ARFGEF3 ATP6V1H ZFYVE9 PTPRS RHOBTB2 ABCB11 AP1G2 RAP2C SH3BP5 | 5.17e-04 | 1307 | 152 | 21 | GO:0030659 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 5.34e-04 | 317 | 152 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | vesicle membrane | GRIPAP1 RAP2A MOSPD2 SEC24A SH3GL2 UBR4 LRRK2 RAB11FIP1 ABCA7 DENND4C EHD4 STAB1 ARFGEF3 ATP6V1H ZFYVE9 PTPRS RHOBTB2 ABCB11 AP1G2 RAP2C SH3BP5 | 6.18e-04 | 1325 | 152 | 21 | GO:0012506 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.21e-04 | 94 | 152 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 7.73e-04 | 6 | 152 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 9.82e-04 | 104 | 152 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 1.08e-03 | 7 | 152 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.08e-03 | 28 | 152 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1G SWAP70 APC2 ACTA1 ACTA2 ACTC1 ACTG2 CIT ABCA7 SGCE ATP2B2 | 1.10e-03 | 500 | 152 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.17e-03 | 161 | 152 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.21e-03 | 109 | 152 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.29e-03 | 164 | 152 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.31e-03 | 360 | 152 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.37e-03 | 112 | 152 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | lamellipodium | 1.50e-03 | 230 | 152 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.59e-03 | 171 | 152 | 6 | GO:0034399 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.60e-03 | 32 | 152 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | filopodium | 2.07e-03 | 123 | 152 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | laminin complex | 2.27e-03 | 10 | 152 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DOCK1 GRIPAP1 KALRN ACTBL2 SH3GL2 LRRK2 ARFGEF2 ACTC1 PTPRS PLCB1 DNM1 ATP2B2 ATP2B3 DCLK1 | 2.59e-03 | 817 | 152 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | nuclear chromosome | 2.62e-03 | 254 | 152 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | cohesin complex | 2.77e-03 | 11 | 152 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | cell body | ADCY10 PDE1A GRIPAP1 PDE1B KALRN CYP11A1 SH3GL2 ACTA1 ACTA2 LRRK2 ACTC1 ACTG2 CIT PTPRS ATP2B2 | 3.22e-03 | 929 | 152 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | nuclear matrix | 3.61e-03 | 140 | 152 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 3.76e-03 | 43 | 152 | 3 | GO:0097431 | |
| GeneOntologyCellularComponent | Swr1 complex | 3.89e-03 | 13 | 152 | 2 | GO:0000812 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.89e-03 | 13 | 152 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 4.40e-03 | 91 | 152 | 4 | GO:0000794 | |
| Domain | ACTINS_1 | 5.93e-12 | 8 | 147 | 6 | PS00406 | |
| Domain | ARM-type_fold | DOCK1 DOCK2 STAG1 TNPO2 UBR4 APC2 LRRK2 ARFGEF2 ARFGEF1 ZYG11B NCAPG2 RYR3 ARFGEF3 PPP4R3B ATP6V1H AP1G2 TAF2 STAG2 | 1.90e-10 | 339 | 147 | 18 | IPR016024 |
| Domain | Actin_CS | 1.61e-09 | 16 | 147 | 6 | IPR004001 | |
| Domain | ACTINS_2 | 2.47e-09 | 17 | 147 | 6 | PS00432 | |
| Domain | Dynein_HC_stalk | 5.33e-08 | 14 | 147 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.33e-08 | 14 | 147 | 5 | IPR013602 | |
| Domain | DHC_N2 | 5.33e-08 | 14 | 147 | 5 | PF08393 | |
| Domain | MT | 5.33e-08 | 14 | 147 | 5 | PF12777 | |
| Domain | DHC_fam | 7.95e-08 | 15 | 147 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 7.95e-08 | 15 | 147 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.95e-08 | 15 | 147 | 5 | IPR004273 | |
| Domain | Actin | 1.34e-07 | 31 | 147 | 6 | IPR004000 | |
| Domain | Actin | 1.34e-07 | 31 | 147 | 6 | PF00022 | |
| Domain | ACTIN | 1.34e-07 | 31 | 147 | 6 | SM00268 | |
| Domain | Actin/actin-like_CS | 2.23e-07 | 18 | 147 | 5 | IPR020902 | |
| Domain | ARM-like | DOCK2 STAG1 TNPO2 APC2 LRRK2 ARFGEF2 ARFGEF1 ZYG11B NCAPG2 PPP4R3B ATP6V1H AP1G2 STAG2 | 2.24e-07 | 270 | 147 | 13 | IPR011989 |
| Domain | DHC_N1 | 2.52e-07 | 8 | 147 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.52e-07 | 8 | 147 | 4 | IPR013594 | |
| Domain | ACTINS_ACT_LIKE | 3.00e-07 | 19 | 147 | 5 | PS01132 | |
| Domain | DCB_dom | 1.90e-06 | 4 | 147 | 3 | IPR032629 | |
| Domain | Sec7_C | 1.90e-06 | 4 | 147 | 3 | IPR015403 | |
| Domain | DUF1981 | 1.90e-06 | 4 | 147 | 3 | PF09324 | |
| Domain | DCB | 1.90e-06 | 4 | 147 | 3 | PF16213 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.47e-06 | 14 | 147 | 4 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 3.47e-06 | 14 | 147 | 4 | IPR011704 | |
| Domain | AAA_8 | 3.47e-06 | 14 | 147 | 4 | PF12780 | |
| Domain | AAA_5 | 3.47e-06 | 14 | 147 | 4 | PF07728 | |
| Domain | SEC7 | 6.23e-06 | 16 | 147 | 4 | PS50190 | |
| Domain | Sec7 | 6.23e-06 | 16 | 147 | 4 | SM00222 | |
| Domain | Sec7_dom | 6.23e-06 | 16 | 147 | 4 | IPR000904 | |
| Domain | - | TNPO2 APC2 LRRK2 ARFGEF2 ARFGEF1 ZYG11B NCAPG2 ATP6V1H AP1G2 | 6.71e-05 | 222 | 147 | 9 | 1.25.10.10 |
| Domain | C2 | 8.02e-05 | 131 | 147 | 7 | PF00168 | |
| Domain | C2 | 1.06e-04 | 137 | 147 | 7 | SM00239 | |
| Domain | C2 | 1.33e-04 | 142 | 147 | 7 | PS50004 | |
| Domain | G_DYNAMIN_dom | 1.63e-04 | 14 | 147 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 1.63e-04 | 14 | 147 | 3 | PS51718 | |
| Domain | - | 1.72e-04 | 148 | 147 | 7 | 2.60.40.150 | |
| Domain | PDEase_N | 1.84e-04 | 3 | 147 | 2 | IPR013706 | |
| Domain | PDEase_I_N | 1.84e-04 | 3 | 147 | 2 | PF08499 | |
| Domain | Dynamin_GTPase | 2.03e-04 | 15 | 147 | 3 | IPR001401 | |
| Domain | EF-hand_like | 2.03e-04 | 15 | 147 | 3 | PF09279 | |
| Domain | Dynamin_SF | 2.03e-04 | 15 | 147 | 3 | IPR022812 | |
| Domain | PI-PLC-Y | 2.03e-04 | 15 | 147 | 3 | PF00387 | |
| Domain | PLCYc | 2.03e-04 | 15 | 147 | 3 | SM00149 | |
| Domain | Dynamin_N | 2.03e-04 | 15 | 147 | 3 | PF00350 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.03e-04 | 15 | 147 | 3 | IPR001711 | |
| Domain | - | 2.03e-04 | 15 | 147 | 3 | 1.10.1000.11 | |
| Domain | PIPLC_Y_DOMAIN | 2.03e-04 | 15 | 147 | 3 | PS50008 | |
| Domain | Sec7 | 2.03e-04 | 15 | 147 | 3 | PF01369 | |
| Domain | PI-PLC_fam | 2.03e-04 | 15 | 147 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.03e-04 | 15 | 147 | 3 | IPR015359 | |
| Domain | Sec7_alpha_orthog | 2.03e-04 | 15 | 147 | 3 | IPR023394 | |
| Domain | - | ADCY10 DNHD1 RAP2A LRRK2 ABCA7 EHD4 HNRNPUL2 RHOBTB2 ABCB11 DNM1 RAP2C DNAH5 DNAH8 DNAH9 MX2 DNAH11 | 2.66e-04 | 746 | 147 | 16 | 3.40.50.300 |
| Domain | C2_dom | 3.22e-04 | 164 | 147 | 7 | IPR000008 | |
| Domain | PI-PLC-X | 3.57e-04 | 18 | 147 | 3 | PF00388 | |
| Domain | PLCXc | 3.57e-04 | 18 | 147 | 3 | SM00148 | |
| Domain | ATP_Ca_trans_C | 3.65e-04 | 4 | 147 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 3.65e-04 | 4 | 147 | 2 | PF12424 | |
| Domain | SCD | 3.65e-04 | 4 | 147 | 2 | PS51425 | |
| Domain | SCD | 3.65e-04 | 4 | 147 | 2 | IPR020839 | |
| Domain | STAG | 3.65e-04 | 4 | 147 | 2 | PF08514 | |
| Domain | STAG | 3.65e-04 | 4 | 147 | 2 | IPR013721 | |
| Domain | Sec7_N | 3.65e-04 | 4 | 147 | 2 | IPR032691 | |
| Domain | Sec7_N | 3.65e-04 | 4 | 147 | 2 | PF12783 | |
| Domain | P-type_ATPase_IIB | 3.65e-04 | 4 | 147 | 2 | IPR006408 | |
| Domain | P-loop_NTPase | ADCY10 MYO1G DNHD1 RAP2A LRRK2 ABCA7 EHD4 HNRNPUL2 RHOBTB2 ABCB11 DNM1 RAP2C DNAH5 DNAH8 DNAH9 MX2 DNAH11 | 3.73e-04 | 848 | 147 | 17 | IPR027417 |
| Domain | PDEase | 4.22e-04 | 19 | 147 | 3 | IPR023088 | |
| Domain | PIPLC_X_DOMAIN | 4.22e-04 | 19 | 147 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.22e-04 | 19 | 147 | 3 | IPR000909 | |
| Domain | PDEase_I | 5.73e-04 | 21 | 147 | 3 | PF00233 | |
| Domain | PDEASE_I | 5.73e-04 | 21 | 147 | 3 | PS00126 | |
| Domain | PDEase_CS | 5.73e-04 | 21 | 147 | 3 | IPR023174 | |
| Domain | DOCK_N | 6.06e-04 | 5 | 147 | 2 | PF16172 | |
| Domain | DOCK_N | 6.06e-04 | 5 | 147 | 2 | IPR032376 | |
| Domain | - | 6.59e-04 | 22 | 147 | 3 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 7.54e-04 | 23 | 147 | 3 | IPR002073 | |
| Domain | HD/PDEase_dom | 8.56e-04 | 24 | 147 | 3 | IPR003607 | |
| Domain | HDc | 8.56e-04 | 24 | 147 | 3 | SM00471 | |
| Domain | Dynamin_central | 9.04e-04 | 6 | 147 | 2 | IPR000375 | |
| Domain | GED | 9.04e-04 | 6 | 147 | 2 | SM00302 | |
| Domain | Dynamin_M | 9.04e-04 | 6 | 147 | 2 | PF01031 | |
| Domain | GED_dom | 9.04e-04 | 6 | 147 | 2 | IPR020850 | |
| Domain | GED | 9.04e-04 | 6 | 147 | 2 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 9.04e-04 | 6 | 147 | 2 | IPR019762 | |
| Domain | GED | 9.04e-04 | 6 | 147 | 2 | PF02212 | |
| Domain | GED | 9.04e-04 | 6 | 147 | 2 | IPR003130 | |
| Domain | - | 9.68e-04 | 25 | 147 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 9.68e-04 | 25 | 147 | 3 | IPR017946 | |
| Domain | AAA | 9.82e-04 | 144 | 147 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 9.82e-04 | 144 | 147 | 6 | IPR003593 | |
| Domain | HECT | 1.22e-03 | 27 | 147 | 3 | PF00632 | |
| Domain | HECTc | 1.22e-03 | 27 | 147 | 3 | SM00119 | |
| Domain | HECT_dom | 1.22e-03 | 27 | 147 | 3 | IPR000569 | |
| Domain | HECT | 1.22e-03 | 27 | 147 | 3 | PS50237 | |
| Domain | G_DYNAMIN_1 | 1.26e-03 | 7 | 147 | 2 | PS00410 | |
| Domain | DYNc | 1.26e-03 | 7 | 147 | 2 | SM00053 | |
| Domain | PH | 1.63e-03 | 278 | 147 | 8 | SM00233 | |
| Domain | EGF_LAM_2 | 1.66e-03 | 30 | 147 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.66e-03 | 30 | 147 | 3 | PS01248 | |
| Domain | PH_DOMAIN | 1.67e-03 | 279 | 147 | 8 | PS50003 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK1 DOCK2 MOSPD2 SWAP70 KALRN WWP2 KTN1 ACBD5 ACTC1 CIT CYFIP2 RHOBTB2 ARHGEF9 PDE5A | 2.58e-05 | 450 | 119 | 14 | M27078 |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.93e-05 | 43 | 119 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.67e-05 | 45 | 119 | 5 | M47670 | |
| Pathway | REACTOME_CGMP_EFFECTS | 6.74e-05 | 10 | 119 | 3 | MM15054 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.29e-05 | 27 | 119 | 4 | M47755 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 7.75e-05 | 165 | 119 | 8 | MM15026 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK1 DOCK2 MOSPD2 SWAP70 KALRN WWP2 KTN1 ACBD5 ACTC1 CYFIP2 RHOBTB2 ARHGEF9 PDE5A | 8.44e-05 | 439 | 119 | 13 | MM15595 |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.58e-04 | 13 | 119 | 3 | MM15015 | |
| Pathway | REACTOME_CGMP_EFFECTS | 3.03e-04 | 16 | 119 | 3 | M902 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.22e-04 | 203 | 119 | 8 | M5485 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 DOCK2 MOSPD2 SWAP70 KALRN WWP2 KTN1 ACBD5 ACTC1 CIT CYFIP2 TUBB1 RHOBTB2 ARHGEF9 PDE5A SCAI | 3.56e-04 | 720 | 119 | 16 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 DOCK2 MOSPD2 SWAP70 KALRN WWP2 KTN1 ACBD5 ACTC1 CYFIP2 TUBB1 RHOBTB2 ARHGEF9 PDE5A SCAI | 3.65e-04 | 649 | 119 | 15 | MM15690 |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 4.51e-04 | 76 | 119 | 5 | MM15051 | |
| Pathway | PID_RHOA_PATHWAY | 5.51e-04 | 45 | 119 | 4 | M12 | |
| Pubmed | 1.46e-09 | 26 | 154 | 6 | 24742657 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 5.51e-09 | 6 | 154 | 4 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 5.51e-09 | 6 | 154 | 4 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 5.51e-09 | 6 | 154 | 4 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 5.51e-09 | 6 | 154 | 4 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 5.51e-09 | 6 | 154 | 4 | 11709093 | |
| Pubmed | 5.51e-09 | 6 | 154 | 4 | 10049817 | ||
| Pubmed | 5.51e-09 | 6 | 154 | 4 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 5.51e-09 | 6 | 154 | 4 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 5.51e-09 | 6 | 154 | 4 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 5.51e-09 | 6 | 154 | 4 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 5.51e-09 | 6 | 154 | 4 | 8661406 | |
| Pubmed | 5.51e-09 | 6 | 154 | 4 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 5.51e-09 | 6 | 154 | 4 | 23875777 | |
| Pubmed | 5.51e-09 | 6 | 154 | 4 | 9841925 | ||
| Pubmed | MOSPD2 SEC24A ACTBL2 ACTA1 ACBD5 ZYG11B RAB11FIP1 PPM1J ZYX CYFIP2 EHD4 PPP4R3B NOP14 ZFYVE9 SLC12A4 PTPRG PTPRS PEX19 G6PD PTPN20 NIN | 8.77e-09 | 1049 | 154 | 21 | 27880917 | |
| Pubmed | FKBP15 IQSEC3 PDE1B KALRN SYNE1 KTN1 SH3GL2 UBR4 APC2 LMNB2 CIT CYFIP2 HNRNPUL2 PTPRS PLCB1 PLCL1 DNM1 DCLK1 SH3BP5 SMG6 | 1.11e-08 | 963 | 154 | 20 | 28671696 | |
| Pubmed | 1.28e-08 | 7 | 154 | 4 | 22535526 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.28e-08 | 7 | 154 | 4 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.28e-08 | 7 | 154 | 4 | 22640593 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.28e-08 | 7 | 154 | 4 | 17504171 | |
| Pubmed | 1.28e-08 | 7 | 154 | 4 | 22465675 | ||
| Pubmed | 1.28e-08 | 7 | 154 | 4 | 31178125 | ||
| Pubmed | IQSEC3 KALRN SYNE1 ACTBL2 KTN1 ACTA1 ARFGEF2 CIT NDUFB7 CYFIP2 GSTM1 ATP6V1H HNRNPUL2 PTPRS TOLLIP KMT2A PLCL1 FH DNM1 ATP2B2 ATP2B3 DCLK1 SCAI DNAH11 | 2.08e-08 | 1431 | 154 | 24 | 37142655 | |
| Pubmed | 2.55e-08 | 8 | 154 | 4 | 14694110 | ||
| Pubmed | 2.55e-08 | 8 | 154 | 4 | 20147394 | ||
| Pubmed | 2.55e-08 | 8 | 154 | 4 | 23260110 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.95e-08 | 22 | 154 | 5 | 16526095 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 4.58e-08 | 9 | 154 | 4 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 4.58e-08 | 9 | 154 | 4 | 8892894 | |
| Pubmed | 4.58e-08 | 9 | 154 | 4 | 18775311 | ||
| Pubmed | 7.60e-08 | 10 | 154 | 4 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 7.60e-08 | 10 | 154 | 4 | 1991513 | |
| Pubmed | 7.60e-08 | 10 | 154 | 4 | 23575248 | ||
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 8.51e-08 | 3 | 154 | 3 | 7780165 | |
| Pubmed | 1.19e-07 | 11 | 154 | 4 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 1.19e-07 | 11 | 154 | 4 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 1.19e-07 | 11 | 154 | 4 | 19639585 | |
| Pubmed | 1.78e-07 | 12 | 154 | 4 | 23071112 | ||
| Pubmed | 3.57e-07 | 14 | 154 | 4 | 21923909 | ||
| Pubmed | 3.57e-07 | 14 | 154 | 4 | 17411366 | ||
| Pubmed | 7.16e-07 | 163 | 154 | 8 | 16512683 | ||
| Pubmed | 8.41e-07 | 17 | 154 | 4 | 17360745 | ||
| Pubmed | 8.41e-07 | 17 | 154 | 4 | 8997639 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 26909801 | ||
| Pubmed | DOCK2 MYO1G FKBP15 MOSPD2 WWP2 KTN1 UBR4 ACBD5 ARFGEF2 ACTC1 CIT NCAPG2 CYFIP2 EHD4 NBAS NOP14 HNRNPUL2 G6PD STAG2 | 1.12e-06 | 1168 | 154 | 19 | 19946888 | |
| Pubmed | STAG1 KALRN TNPO2 SYNE1 UBR4 APC2 ARFGEF2 CIT NDUFB7 FAF1 RYR3 STAB1 PPP4R3B COG1 TOLLIP DNM1 DCLK1 SMYD3 SCAI SH3BP5 | 1.12e-06 | 1285 | 154 | 20 | 35914814 | |
| Pubmed | 1.19e-06 | 42 | 154 | 5 | 35705031 | ||
| Pubmed | A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. | 1.51e-06 | 44 | 154 | 5 | 32492419 | |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 33347437 | ||
| Pubmed | 1.71e-06 | 183 | 154 | 8 | 23956138 | ||
| Pubmed | 1.96e-06 | 251 | 154 | 9 | 27507650 | ||
| Pubmed | FKBP15 GRIPAP1 MOSPD2 KTN1 ACBD5 ARFGEF2 ARFGEF1 DENND4C ARFGEF3 NBAS ZFYVE9 SLC12A4 | 2.81e-06 | 504 | 154 | 12 | 34432599 | |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 9256245 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 2.94e-06 | 7 | 154 | 3 | 9384381 | |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 30289203 | ||
| Pubmed | ING3 SYNE1 ACTBL2 KTN1 ACBD5 TOPBP1 RAB11FIP1 CIT CYFIP2 MED24 BRD8 NOP14 ARHGEF9 TOLLIP KMT2A TAF2 MICU2 RAP2C STAG2 DCLK1 SMG6 | 3.05e-06 | 1497 | 154 | 21 | 31527615 | |
| Pubmed | 3.07e-06 | 23 | 154 | 4 | 14966270 | ||
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 3.07e-06 | 23 | 154 | 4 | 22004035 | |
| Pubmed | 4.58e-06 | 209 | 154 | 8 | 26389662 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 20096780 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 37871017 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.92e-06 | 281 | 154 | 9 | 28706196 | |
| Pubmed | STAG1 SYNE1 ACTBL2 KTN1 UBR4 ACTA1 ACTA2 ACTC1 ACTG2 LMNB2 CYFIP2 EHD4 NOP14 SLC12A4 COG1 KMT2A DNAH8 ATP2B2 ATP2B3 STAG2 | 6.34e-06 | 1442 | 154 | 20 | 35575683 | |
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 7.01e-06 | 9 | 154 | 3 | 12297046 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GRIPAP1 SWAP70 SEC24A ACTBL2 KTN1 UBR4 ACTA1 ARFGEF2 DDI2 UNC13D ZYX FAF1 EHD4 PPP4R3B ATP6V1H HNRNPUL2 TOLLIP FH DNM1 G6PD | 7.23e-06 | 1455 | 154 | 20 | 22863883 |
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 9.99e-06 | 10 | 154 | 3 | 21749862 | |
| Pubmed | 1.21e-05 | 32 | 154 | 4 | 23369715 | ||
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 22207710 | ||
| Pubmed | 1.37e-05 | 11 | 154 | 3 | 15196461 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.43e-05 | 321 | 154 | 9 | 32098917 | |
| Pubmed | DOCK1 KALRN WWP2 TOPBP1 RAB11FIP1 ZYX DENND4C PPP4R3B BRD8 HNRNPUL2 SH3BP5 | 1.63e-05 | 503 | 154 | 11 | 16964243 | |
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 1.82e-05 | 12 | 154 | 3 | 31042497 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 31421907 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32778134 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20706863 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26745340 | ||
| Pubmed | Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. | 1.95e-05 | 2 | 154 | 2 | 21345334 | |
| Pubmed | Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma. | 1.95e-05 | 2 | 154 | 2 | 22898004 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 22715410 | ||
| Pubmed | Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1. | 1.95e-05 | 2 | 154 | 2 | 28430577 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 8187550 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 3023046 | ||
| Pubmed | Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1. | 1.95e-05 | 2 | 154 | 2 | 28467910 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23918382 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30125583 | ||
| Pubmed | Gender differences in genetic susceptibility for lung cancer. | 1.95e-05 | 2 | 154 | 2 | 11137199 | |
| Pubmed | Distinct functions of human cohesin-SA1 and cohesin-SA2 in double-strand break repair. | 1.95e-05 | 2 | 154 | 2 | 24324008 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17360629 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10716990 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32357925 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 18203920 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 3075543 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19383890 | ||
| Pubmed | Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. | 1.95e-05 | 2 | 154 | 2 | 9114002 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 18417613 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34560329 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34648034 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32725632 | ||
| Pubmed | Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. | 1.95e-05 | 2 | 154 | 2 | 19468071 | |
| Interaction | NPTN interactions | STAG1 TNPO2 ACTBL2 ACTA2 ARFGEF2 ARFGEF1 ARFGEF3 ATP6V1H COG1 ZFYVE26 ATP2B2 ATP2B3 STAG2 SCAI | 2.01e-08 | 278 | 149 | 14 | int:NPTN |
| Interaction | ACTG1 interactions | IKZF3 MNS1 WWP2 ACTBL2 SH3GL2 ACTA1 ACTA2 LRRK2 TSGA10 TOPBP1 ACTC1 ACTG2 ACTL6A FAF1 CYFIP2 RHOBTB2 TOLLIP G6PD | 5.93e-08 | 520 | 149 | 18 | int:ACTG1 |
| Interaction | POTEJ interactions | 1.06e-07 | 52 | 149 | 7 | int:POTEJ | |
| Interaction | ACTG2 interactions | 1.59e-06 | 49 | 149 | 6 | int:ACTG2 | |
| Interaction | SIGLECL1 interactions | 1.96e-06 | 113 | 149 | 8 | int:SIGLECL1 | |
| Interaction | VASP interactions | SWAP70 SEC24A WWP2 UBR4 ACTA1 ACTC1 TEX9 ZYX CYFIP2 ARFGEF3 ZFYVE9 PEX19 | 1.99e-06 | 294 | 149 | 12 | int:VASP |
| Interaction | CD40 interactions | 2.09e-06 | 153 | 149 | 9 | int:CD40 | |
| Interaction | TNIK interactions | FKBP15 IQSEC3 RAP2A KALRN SYNE1 SH3GL2 LMNB2 CIT CYFIP2 PTPRS TOLLIP DNM1 DCLK1 | 5.29e-06 | 381 | 149 | 13 | int:TNIK |
| Interaction | GPR17 interactions | STAG1 TNPO2 ARFGEF2 ARFGEF1 ARFGEF3 PPP4R3B NBAS ATP6V1H COG1 STAG2 EVI5L | 8.58e-06 | 283 | 149 | 11 | int:GPR17 |
| Interaction | EDNRB interactions | 9.71e-06 | 39 | 149 | 5 | int:EDNRB | |
| Interaction | RAC1 interactions | DOCK1 DOCK2 ARL2BP SWAP70 KALRN WWP2 KTN1 ACTA1 LRRK2 ACTC1 LMNB2 RAB11FIP1 CIT DENND4C CYFIP2 EHD4 SLC12A4 PTPRG PTPRS TOLLIP SGCE RAP2C | 1.16e-05 | 1063 | 149 | 22 | int:RAC1 |
| Interaction | LAMP2 interactions | GRIPAP1 RAP2A MOSPD2 KTN1 ARFGEF2 ARFGEF1 RAB11FIP1 DENND4C ARFGEF3 ATP6V1H ZFYVE9 SLC12A4 PTPRG PLCB1 ZFYVE26 FH | 1.18e-05 | 609 | 149 | 16 | int:LAMP2 |
| Interaction | P2RY10 interactions | 1.39e-05 | 106 | 149 | 7 | int:P2RY10 | |
| Interaction | MRGBP interactions | 1.66e-05 | 109 | 149 | 7 | int:MRGBP | |
| Interaction | LIMA1 interactions | ACTBL2 ACTA1 ACTA2 LRRK2 ACTC1 ACTG2 CIT DENND4C FAF1 TOLLIP RAP2C DCLK1 SH3BP5 | 1.87e-05 | 429 | 149 | 13 | int:LIMA1 |
| Interaction | CYP2B6 interactions | 2.16e-05 | 8 | 149 | 3 | int:CYP2B6 | |
| Interaction | C3orf18 interactions | 2.36e-05 | 115 | 149 | 7 | int:C3orf18 | |
| Interaction | PTGER3 interactions | 2.79e-05 | 118 | 149 | 7 | int:PTGER3 | |
| Interaction | RAPGEF4 interactions | 3.35e-05 | 50 | 149 | 5 | int:RAPGEF4 | |
| Interaction | FIS1 interactions | 4.03e-05 | 221 | 149 | 9 | int:FIS1 | |
| Interaction | PFN3 interactions | 4.58e-05 | 10 | 149 | 3 | int:PFN3 | |
| Interaction | ANGPTL8 interactions | 4.58e-05 | 10 | 149 | 3 | int:ANGPTL8 | |
| Interaction | MFSD4A interactions | 4.63e-05 | 225 | 149 | 9 | int:MFSD4A | |
| Interaction | P2RY8 interactions | 5.69e-05 | 179 | 149 | 8 | int:P2RY8 | |
| Interaction | PNKD interactions | 5.71e-05 | 132 | 149 | 7 | int:PNKD | |
| Interaction | WASH8P interactions | 6.26e-05 | 11 | 149 | 3 | int:WASH8P | |
| Interaction | LAMP3 interactions | RAP2A MOSPD2 SEC24A KTN1 ARFGEF2 ARFGEF1 RAB11FIP1 NCAPG2 DENND4C ARFGEF3 ZFYVE9 SLC12A4 PTPRG | 6.75e-05 | 486 | 149 | 13 | int:LAMP3 |
| Interaction | IFITM1 interactions | FKBP15 GRIPAP1 SEC24A ACTBL2 UBR4 FSD1 LMNB2 RAB11FIP1 ARFGEF3 ZFYVE9 TOLLIP | 6.87e-05 | 355 | 149 | 11 | int:IFITM1 |
| Interaction | SCIN interactions | 6.90e-05 | 58 | 149 | 5 | int:SCIN | |
| Interaction | CFAP53 interactions | 7.73e-05 | 31 | 149 | 4 | int:CFAP53 | |
| Interaction | GPR45 interactions | TNPO2 ARFGEF1 NCAPG2 EDEM3 ATP6V1H COG1 PEX19 RARS2 ATP2B2 EVI5L | 8.13e-05 | 300 | 149 | 10 | int:GPR45 |
| Interaction | CDCA5 interactions | 8.29e-05 | 140 | 149 | 7 | int:CDCA5 | |
| Interaction | TSGA10IP interactions | 8.29e-05 | 140 | 149 | 7 | int:TSGA10IP | |
| Interaction | C17orf78 interactions | 8.30e-05 | 12 | 149 | 3 | int:C17orf78 | |
| Interaction | JAZF1 interactions | 8.80e-05 | 61 | 149 | 5 | int:JAZF1 | |
| Interaction | KCTD13 interactions | IQSEC3 KALRN SYNE1 ACTBL2 KTN1 ACTA1 ARFGEF2 CIT NDUFB7 FAF1 CYFIP2 ATP6V1H HNRNPUL2 PTPRS TOLLIP KMT2A PLCL1 FH DNM1 ATP2B2 ATP2B3 DCLK1 SCAI DNAH11 | 8.81e-05 | 1394 | 149 | 24 | int:KCTD13 |
| Interaction | FPR1 interactions | 1.13e-04 | 147 | 149 | 7 | int:FPR1 | |
| Interaction | BOD1L1 interactions | 1.22e-04 | 149 | 149 | 7 | int:BOD1L1 | |
| Interaction | RAB9A interactions | FKBP15 GRIPAP1 SEC24A KTN1 ARFGEF2 ARFGEF1 RAB11FIP1 DENND4C ARFGEF3 NBAS ZFYVE9 RHOBTB2 PEX19 ZFYVE26 | 1.38e-04 | 595 | 149 | 14 | int:RAB9A |
| Interaction | ABRA interactions | 1.41e-04 | 36 | 149 | 4 | int:ABRA | |
| Interaction | FBXO40 interactions | 1.69e-04 | 15 | 149 | 3 | int:FBXO40 | |
| Interaction | NAA80 interactions | 1.69e-04 | 15 | 149 | 3 | int:NAA80 | |
| Interaction | ABLIM3 interactions | 1.93e-04 | 39 | 149 | 4 | int:ABLIM3 | |
| Interaction | RHOA interactions | IKZF3 MOSPD2 WWP2 KTN1 ACTA2 ACBD5 LRRK2 ACTC1 LMNB2 RAB11FIP1 CIT CYFIP2 ZFYVE9 SLC12A4 PTPRG HNRNPUL2 PTPRS RHOBTB2 RARS2 RAP2C MX2 | 2.02e-04 | 1199 | 149 | 21 | int:RHOA |
| Interaction | MAPT interactions | STAG1 TNPO2 ACTBL2 KTN1 ACTA1 ACTA2 LRRK2 ACTC1 FSD1 CYFIP2 GSTM1 FSD1L ATP6V1H HNRNPUL2 TOLLIP DNM1 G6PD ATP2B3 DCLK1 EVI5L | 2.23e-04 | 1119 | 149 | 20 | int:MAPT |
| Interaction | REG3A interactions | 2.50e-04 | 17 | 149 | 3 | int:REG3A | |
| Interaction | MGARP interactions | 2.52e-04 | 222 | 149 | 8 | int:MGARP | |
| Interaction | FOXR1 interactions | 3.10e-04 | 44 | 149 | 4 | int:FOXR1 | |
| Interaction | LNPK interactions | GRIPAP1 MOSPD2 SYNE1 SEC24A KTN1 SH3GL2 ACBD5 LMNB2 CYFIP2 NBAS | 3.18e-04 | 355 | 149 | 10 | int:LNPK |
| Interaction | ACTA2 interactions | 3.18e-04 | 355 | 149 | 10 | int:ACTA2 | |
| Interaction | ANPEP interactions | 3.18e-04 | 174 | 149 | 7 | int:ANPEP | |
| Interaction | TMSB4X interactions | 3.18e-04 | 80 | 149 | 5 | int:TMSB4X | |
| Interaction | SHANK3 interactions | KALRN SYNE1 KTN1 SH3GL2 CIT CYFIP2 ARFGEF3 PLCB1 DNM1 ATP2B2 DCLK1 SH3BP5 | 3.26e-04 | 496 | 149 | 12 | int:SHANK3 |
| Interaction | BUB3 interactions | 3.38e-04 | 232 | 149 | 8 | int:BUB3 | |
| Interaction | PPP1R13B interactions | 3.41e-04 | 176 | 149 | 7 | int:PPP1R13B | |
| Interaction | FAM234A interactions | 3.51e-04 | 126 | 149 | 6 | int:FAM234A | |
| Interaction | LRRC20 interactions | 3.52e-04 | 19 | 149 | 3 | int:LRRC20 | |
| Interaction | DISC1 interactions | GRIPAP1 MNS1 KALRN SYNE1 ACTBL2 TSGA10 ACTC1 FSD1 TEX9 CIT SH3BP5 | 3.56e-04 | 429 | 149 | 11 | int:DISC1 |
| Interaction | PLEC interactions | ACTBL2 ACTA1 ACTA2 LRRK2 TSGA10 ACTC1 ACTG2 CIT CYFIP2 AXDND1 DNAH5 | 3.63e-04 | 430 | 149 | 11 | int:PLEC |
| Interaction | GJA1 interactions | KALRN SEC24A KTN1 ACTA2 ARFGEF1 DENND4C CYFIP2 NBAS ZFYVE9 SLC12A4 PTPRG COG1 TAS1R2 | 4.01e-04 | 583 | 149 | 13 | int:GJA1 |
| Interaction | RHOC interactions | MOSPD2 WWP2 KTN1 ACBD5 ACTC1 LMNB2 RAB11FIP1 CIT SLC12A4 HNRNPUL2 PTPRS KMT2A RAP2C | 4.07e-04 | 584 | 149 | 13 | int:RHOC |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | ZNF823 BEST2 TNPO2 APC2 FSD1 LMNB2 NDUFB7 ABCA7 CLEC17A PTPRS EVI5L | 8.57e-05 | 797 | 154 | 11 | chr19p13 |
| GeneFamily | Actins | 1.42e-08 | 6 | 102 | 4 | 929 | |
| GeneFamily | Dyneins, axonemal | 2.15e-06 | 17 | 102 | 4 | 536 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.58e-04 | 19 | 102 | 3 | 832 | |
| GeneFamily | Phosphodiesterases | 3.24e-04 | 24 | 102 | 3 | 681 | |
| GeneFamily | Cohesin complex | 8.63e-04 | 8 | 102 | 2 | 1060 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.19e-04 | 34 | 102 | 3 | 487 | |
| GeneFamily | ATPases Ca2+ transporting | 1.11e-03 | 9 | 102 | 2 | 1209 | |
| GeneFamily | EF-hand domain containing | 1.51e-03 | 219 | 102 | 6 | 863 | |
| GeneFamily | Laminin subunits | 2.00e-03 | 12 | 102 | 2 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 2.13e-03 | 160 | 102 | 5 | 555 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.98e-03 | 51 | 102 | 3 | 870 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.17e-03 | 21 | 102 | 2 | 813 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP | 5.42e-06 | 163 | 153 | 8 | M6763 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500 | 9.22e-07 | 48 | 146 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_100 | 2.33e-05 | 83 | 146 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_100_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 2.85e-05 | 26 | 146 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 3.86e-05 | 28 | 146 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.18e-05 | 92 | 146 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 8.86e-05 | 152 | 146 | 7 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 9.74e-05 | 107 | 146 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | DOCK1 KALRN ACTA1 ACTA2 ARFGEF2 ACTC1 ACTG2 RYR3 ARHGEF9 PDE5A DNM1 | 1.21e-04 | 407 | 146 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.22e-04 | 160 | 146 | 7 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.31e-04 | 277 | 146 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100 | 1.36e-04 | 15 | 146 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.46e-04 | 281 | 146 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | IKZF3 SH3GL2 ACTA1 ACTA2 ARFGEF2 ACTC1 ACTG2 LAMB3 MFSD4A ADAMTSL3 RYR3 EHD4 GSTM1 PDE5A PLCL1 | 1.67e-04 | 734 | 146 | 15 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_500 | 1.78e-04 | 41 | 146 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 1.90e-04 | 77 | 146 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_200 | 2.02e-04 | 17 | 146 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.15e-04 | 79 | 146 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100 | 2.85e-04 | 19 | 146 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_100 | 2.85e-04 | 19 | 146 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_1000 | MYO1G IKZF3 SH3GL2 ACTA1 ACTA2 ARFGEF2 ACTG2 LAMB3 MFSD4A UNC13D LAMC2 EHD4 GSTM1 ABCB11 G6PD | 3.11e-04 | 778 | 146 | 15 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_500 | 3.18e-04 | 187 | 146 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_200 | 3.55e-04 | 88 | 146 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 3.55e-04 | 88 | 146 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 3.60e-04 | 136 | 146 | 6 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.75e-04 | 89 | 146 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200 | 3.86e-04 | 50 | 146 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 4.15e-04 | 91 | 146 | 5 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 4.16e-04 | 395 | 146 | 10 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | DOCK1 KALRN WWP2 ACTA1 ACTA2 ARFGEF2 ACTC1 ACTG2 LAMB3 ZYG11B RYR3 PTPRG ARHGEF9 PDE5A DNM1 | 4.50e-04 | 806 | 146 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 4.96e-04 | 404 | 146 | 10 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | STAG1 CYP11A1 SH3GL2 ACTG2 G2E3 LMNB2 TEX11 ZYX FAF1 GSTM1 PPP4R3B PTPRS PEX19 G6PD SH3BP5 | 5.31e-04 | 819 | 146 | 15 | gudmap_developingGonad_P2_testes_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.83e-04 | 98 | 146 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.27e-04 | 151 | 146 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_200 | 6.55e-04 | 25 | 146 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | FKBP15 KALRN APC2 ACBD5 TSGA10 DENND4C FSD1L PTPRS ATP2B2 DCLK1 | 6.57e-04 | 419 | 146 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K1 |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-08 | 189 | 154 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-07 | 179 | 154 | 8 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.86e-07 | 186 | 154 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-07 | 191 | 154 | 8 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 194 | 154 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.26e-07 | 196 | 154 | 8 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-07 | 196 | 154 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.43e-07 | 197 | 154 | 8 | e28b1b154d9588dce07c123b36f7f01fa90a5fc1 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.60e-07 | 198 | 154 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-07 | 198 | 154 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-07 | 199 | 154 | 8 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-06 | 177 | 154 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 178 | 154 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.78e-06 | 185 | 154 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 4.06e-06 | 187 | 154 | 7 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-06 | 189 | 154 | 7 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.51e-06 | 190 | 154 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.67e-06 | 191 | 154 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.67e-06 | 191 | 154 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Fibroblast-D_(Pericyte)|World / shred on cell class and cell subclass (v4) | 4.83e-06 | 192 | 154 | 7 | 8c13c351fcc3d88e8c2ffa017e71ff6272cc6fac | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 192 | 154 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-06 | 193 | 154 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 5.00e-06 | 193 | 154 | 7 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.35e-06 | 195 | 154 | 7 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-06 | 195 | 154 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-06 | 196 | 154 | 7 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-06 | 196 | 154 | 7 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 196 | 154 | 7 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.72e-06 | 197 | 154 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.72e-06 | 197 | 154 | 7 | 751ffb8792058384079ebfe94872b3525f1aea84 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 5.72e-06 | 197 | 154 | 7 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-06 | 198 | 154 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.31e-06 | 200 | 154 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | distal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-06 | 200 | 154 | 7 | f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-06 | 200 | 154 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.31e-06 | 200 | 154 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-06 | 200 | 154 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 148 | 154 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 148 | 154 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.00e-05 | 160 | 154 | 6 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | Immune_cells-B_cell|World / Lineage and Cell class | 2.22e-05 | 163 | 154 | 6 | 3a02465de7c2f7cea227e289fb082a1fb6400301 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.38e-05 | 165 | 154 | 6 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 169 | 154 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 171 | 154 | 6 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 171 | 154 | 6 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-05 | 171 | 154 | 6 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-05 | 171 | 154 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 3.01e-05 | 172 | 154 | 6 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 172 | 154 | 6 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.31e-05 | 175 | 154 | 6 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.42e-05 | 176 | 154 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 3.42e-05 | 176 | 154 | 6 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 3.53e-05 | 177 | 154 | 6 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.65e-05 | 178 | 154 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 3.76e-05 | 179 | 154 | 6 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 179 | 154 | 6 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 180 | 154 | 6 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 180 | 154 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 180 | 154 | 6 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 180 | 154 | 6 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-05 | 180 | 154 | 6 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-05 | 181 | 154 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.13e-05 | 182 | 154 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-05 | 182 | 154 | 6 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 182 | 154 | 6 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 182 | 154 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 183 | 154 | 6 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-05 | 184 | 154 | 6 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 154 | 6 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 4.52e-05 | 185 | 154 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-05 | 185 | 154 | 6 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 4.52e-05 | 185 | 154 | 6 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.66e-05 | 186 | 154 | 6 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.66e-05 | 186 | 154 | 6 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 186 | 154 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 186 | 154 | 6 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 154 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 187 | 154 | 6 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 187 | 154 | 6 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 187 | 154 | 6 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 4.80e-05 | 187 | 154 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 187 | 154 | 6 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 187 | 154 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.94e-05 | 188 | 154 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| Computational | Neighborhood of THRA | 1.09e-04 | 54 | 95 | 5 | MORF_THRA | |
| Computational | Neighborhood of ATF2 | STAG1 CYP11A1 ARFGEF2 ADAMTSL3 RYR3 SLC17A1 PTPRS ATP2B2 PTPN20 SMYD3 DRC3 | 1.51e-04 | 330 | 95 | 11 | MORF_ATF2 |
| Computational | Muscle genes. | 3.02e-04 | 37 | 95 | 4 | MODULE_512 | |
| Drug | Nsc687160 | 1.39e-09 | 18 | 152 | 6 | CID005459290 | |
| Drug | tolytoxin | 2.02e-09 | 19 | 152 | 6 | CID006440827 | |
| Drug | NSC312786 | 4.01e-09 | 21 | 152 | 6 | CID000329495 | |
| Drug | AC1L8NVR | 4.01e-09 | 21 | 152 | 6 | CID000384633 | |
| Drug | orthovanadate | PDE1A PDE1B ACTBL2 ACTC1 ACTL6A ATP6V1H BRD8 PTPRG PTPRS PLCB1 ABCB11 PDE5A DNAH9 ATP2B2 G6PD ATP2B3 DNAH11 | 5.71e-09 | 435 | 152 | 17 | CID000061672 |
| Drug | MAPS | ACTBL2 KTN1 ACTA1 ACTA2 ACTC1 ACTG2 FSD1 ACTL6A CIT TUBB1 DNAH9 DCLK1 | 6.28e-09 | 191 | 152 | 12 | CID000066161 |
| Drug | 9-beta-D-arabinofuranosylguanine | DOCK1 DOCK2 PDE1A PDE1B ACTBL2 ACTA1 ACTA2 ARFGEF2 ARFGEF1 ACTC1 ACTG2 PLCD4 ACTL6A CIT TUBB1 BRD8 HNRNPUL2 RHOBTB2 PLCB1 PDE5A DNM1 RAP2C SMG6 | 9.80e-09 | 843 | 152 | 23 | CID000000765 |
| Drug | AC1L8FNU | 1.60e-08 | 44 | 152 | 7 | CID000425429 | |
| Drug | pentoxifylline | IL12A PDE1A PDE1B ACTBL2 SH3GL2 ACTA1 ACTA2 ACTC1 ACTG2 PLCD4 ACTL6A PEX19 PLCB1 PDE5A | 1.77e-08 | 304 | 152 | 14 | CID000004740 |
| Drug | caged ATP | 2.18e-08 | 70 | 152 | 8 | CID000123806 | |
| Drug | azaspiracid | 4.17e-08 | 30 | 152 | 6 | CID006451158 | |
| Drug | Ro-1724 | 5.43e-08 | 110 | 152 | 9 | CID000005087 | |
| Drug | fluorescein isothiocyanate | PDE1A CYP11A1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ATP2B2 ATP2B3 | 5.68e-08 | 147 | 152 | 10 | CID000018730 |
| Drug | AC1L1HS4 | 6.30e-08 | 32 | 152 | 6 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 9.24e-08 | 34 | 152 | 6 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 9.24e-08 | 34 | 152 | 6 | CID000001312 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 1.12e-07 | 86 | 152 | 8 | CID000000805 | |
| Drug | m2-19 | 1.34e-07 | 19 | 152 | 5 | CID000079129 | |
| Drug | vanadyl | PDE1A PDE1B ARFGEF1 BRD8 PTPRG PTPRS PDE5A DNAH5 DNAH8 DNAH9 ATP2B2 G6PD DNAH11 | 1.55e-07 | 307 | 152 | 13 | CID000061671 |
| Drug | C18:1n-7 | 1.90e-07 | 92 | 152 | 8 | CID000122325 | |
| Drug | mDia | 2.07e-07 | 93 | 152 | 8 | CID000128346 | |
| Drug | oryzalin | 2.08e-07 | 63 | 152 | 7 | CID000029393 | |
| Drug | 5-IAF | 2.88e-07 | 66 | 152 | 7 | CID000123822 | |
| Drug | epsilon-ATP | 2.97e-07 | 41 | 152 | 6 | CID000162262 | |
| Drug | nocodazole | MNS1 ACTBL2 APC2 ACTA1 ACTA2 ARFGEF2 ARFGEF1 ACTC1 ACTG2 FSD1 LMNB2 ACTL6A TUBB1 COG1 NIN | 7.66e-07 | 477 | 152 | 15 | CID000004122 |
| Drug | milrinone | 7.74e-07 | 150 | 152 | 9 | CID000004197 | |
| Drug | NpCaM | 7.81e-07 | 48 | 152 | 6 | CID000122259 | |
| Drug | AC1Q6LQU | 7.81e-07 | 48 | 152 | 6 | CID000072380 | |
| Drug | CID5288653 | 1.08e-06 | 28 | 152 | 5 | CID005288653 | |
| Drug | NSC106399 | 1.13e-06 | 51 | 152 | 6 | CID000002887 | |
| Drug | blebbistatin | 1.13e-06 | 116 | 152 | 8 | CID003476986 | |
| Drug | plakin | 1.29e-06 | 82 | 152 | 7 | CID000018752 | |
| Drug | TCNB | 1.38e-06 | 119 | 152 | 8 | CID000008330 | |
| Drug | bumetanide | BEST2 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A SLC12A4 SLC17A1 SLC4A9 | 1.48e-06 | 209 | 152 | 10 | CID000002471 |
| Drug | 3-methylhistidine | 1.77e-06 | 55 | 152 | 6 | CID000064969 | |
| Drug | dihydrocytochalasin B | 2.44e-06 | 58 | 152 | 6 | CID000003064 | |
| Drug | NSC613009 | 2.68e-06 | 130 | 152 | 8 | CID000003800 | |
| Drug | pyrene | 2.84e-06 | 131 | 152 | 8 | CID000031423 | |
| Drug | NSC-351907 | ACTBL2 ACTA1 ACTA2 ARFGEF1 ACTC1 ACTG2 PLCD4 ACTL6A HNRNPUL2 PLCB1 | 3.36e-06 | 229 | 152 | 10 | CID000004016 |
| Drug | manidipine | 3.48e-06 | 95 | 152 | 7 | CID000004008 | |
| Drug | AC1NSKFN | 3.96e-06 | 36 | 152 | 5 | CID005311324 | |
| Drug | NSC3096 | 4.28e-06 | 98 | 152 | 7 | CID000002832 | |
| Drug | dibutyryl cyclic 3',5'-AMP | IL12A PDE1B CYP11A1 ACTBL2 ACTA1 ACTA2 MMP27 ACTC1 ACTG2 LAMC2 ACTL6A ABCA7 ABCB11 PDE5A G6PD | 5.59e-06 | 561 | 152 | 15 | CID000002460 |
| Drug | NSC3260 | 6.74e-06 | 195 | 152 | 9 | CID000220461 | |
| Drug | AC1L1ERT | 6.80e-06 | 69 | 152 | 6 | CID000002920 | |
| Drug | AC1OAGGW | 9.32e-06 | 203 | 152 | 9 | CID006857364 | |
| Drug | CaCl2 | 1.03e-05 | 156 | 152 | 8 | CID000024854 | |
| Drug | nitroglycerin | 1.05e-05 | 206 | 152 | 9 | CID000004510 | |
| Drug | AC1LD8HW | 1.10e-05 | 75 | 152 | 6 | CID000644061 | |
| Drug | HU-211 | 1.17e-05 | 114 | 152 | 7 | CID000107778 | |
| Drug | trifluoperazine | ADCY10 PDE1A PDE1B ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ATP2B2 ATP2B3 | 1.19e-05 | 324 | 152 | 11 | CID000005566 |
| Drug | SIRIUS | 1.29e-05 | 77 | 152 | 6 | CID000091750 | |
| Drug | B0683 | 1.38e-05 | 117 | 152 | 7 | CID006398969 | |
| Drug | AC1L9EF8 | 1.49e-05 | 79 | 152 | 6 | CID000443315 | |
| Drug | sodium | IL12A WWP2 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A CIT RYR3 ATP6V1H SLC12A4 PTPRG SLC17A1 ABCB11 RAP2C ATP2B2 ATP2B3 SLC4A9 | 1.80e-05 | 944 | 152 | 19 | CID000000923 |
| Drug | formamide | 2.27e-05 | 85 | 152 | 6 | CID000000713 | |
| Drug | microcystin-LR | 2.60e-05 | 129 | 152 | 7 | CID000445433 | |
| Drug | MgCl2 | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A TUBB1 DNAH9 ATP2B2 G6PD ATP2B3 | 2.70e-05 | 354 | 152 | 11 | CID000024584 |
| Drug | NSC406942 | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A NCAPG2 RYR3 NOP14 DNM1 DNAH9 ATP2B2 G6PD ATP2B3 | 2.70e-05 | 565 | 152 | 14 | CID000001115 |
| Drug | AC1L1IZE | 2.88e-05 | 131 | 152 | 7 | CID000004799 | |
| Drug | polyproline | DOCK1 ACTBL2 SH3GL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A ZYX SLC4A9 | 3.04e-05 | 295 | 152 | 10 | CID000439587 |
| Drug | AC1NRCMD | 3.15e-05 | 90 | 152 | 6 | CID005289074 | |
| Drug | Formyl | 3.29e-05 | 238 | 152 | 9 | CID000123370 | |
| Drug | AC1L22RD | 3.35e-05 | 91 | 152 | 6 | CID000065183 | |
| Drug | AC1L1JYL | DOCK2 STAG1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 PLCD4 LAMC2 ACTL6A ABCA7 PLCB1 | 3.64e-05 | 434 | 152 | 12 | CID000005262 |
| Drug | AC1NRBPQ | 3.83e-05 | 137 | 152 | 7 | CID005288569 | |
| Drug | eye gene | ADCY10 EVC2 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 PLCD4 ACTL6A PLCB1 PDE5A | 3.94e-05 | 369 | 152 | 11 | CID000004782 |
| Drug | enantio-PAF-C16 | 3.99e-05 | 244 | 152 | 9 | CID000002499 | |
| Drug | AC1L1GXW | 4.03e-05 | 94 | 152 | 6 | CID000003891 | |
| Drug | NSC60597 | 4.40e-05 | 140 | 152 | 7 | CID000003327 | |
| Drug | GTP[S] | DOCK1 RAP2A ACTBL2 ACTA1 ACTA2 ARFGEF1 ACTC1 ACTG2 PLCD4 ACTL6A RYR3 HNRNPUL2 PLCB1 DNM1 | 4.41e-05 | 591 | 152 | 14 | CID000001764 |
| Drug | bistheonellide A | 4.63e-05 | 11 | 152 | 3 | CID006441172 | |
| Drug | Viroisin | 4.63e-05 | 11 | 152 | 3 | CID000119538 | |
| Drug | NSC339663 | 4.82e-05 | 250 | 152 | 9 | CID000003892 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 5.09e-05 | 98 | 152 | 6 | ctd:C014175 | |
| Drug | arabinosyladenine | IL12A PDE1A PDE1B ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A CIT RYR3 ABCB11 PDE5A ATP2B2 G6PD ATP2B3 | 5.26e-05 | 762 | 152 | 16 | CID000000191 |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 5.52e-05 | 197 | 152 | 8 | 6010_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; PC3; HG-U133A | 5.52e-05 | 197 | 152 | 8 | 1923_DN | |
| Drug | dihydrosphingosine | 5.75e-05 | 146 | 152 | 7 | CID000003126 | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 3082_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 6963_DN | |
| Drug | carbachol | ADCY10 PDE1A ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 PLCD4 LAMC2 ACTL6A RYR3 HNRNPUL2 PLCB1 ATP2B2 ATP2B3 | 5.99e-05 | 688 | 152 | 15 | CID000002551 |
| Drug | sulphoxide | 6.03e-05 | 101 | 152 | 6 | CID000008442 | |
| Drug | BFDGE | 6.14e-05 | 12 | 152 | 3 | CID000091511 | |
| Drug | PD-V | 6.14e-05 | 12 | 152 | 3 | CID000444615 | |
| Drug | (2S,3R)-Sphingosine | STAG1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 PLCD4 ACTL6A ABCA7 RYR3 PLCB1 | 6.34e-05 | 389 | 152 | 11 | CID000001104 |
| Drug | sodium nitroprusside | 6.72e-05 | 261 | 152 | 9 | CID000045469 | |
| Drug | beryllium fluoride | 6.73e-05 | 103 | 152 | 6 | CID000024589 | |
| Drug | magnesium | ARL2BP RAP2A PDE1B ACTBL2 ACTA1 ACTA2 MMP27 ACTC1 ACTG2 LAMC2 ACTL6A RYR3 TUBB1 PDE5A DNM1 DNAH5 DNAH8 DNAH9 ATP2B2 G6PD ATP2B3 DNAH11 | 7.09e-05 | 1325 | 152 | 22 | CID000000888 |
| Drug | etheno-NAD | 7.10e-05 | 104 | 152 | 6 | CID005288160 | |
| Drug | fasudil | 7.11e-05 | 151 | 152 | 7 | CID000003547 | |
| Drug | carbodiimide | 7.11e-05 | 151 | 152 | 7 | CID000009864 | |
| Drug | astragaloside A | 7.58e-05 | 34 | 152 | 4 | CID000122690 | |
| Drug | 8-hydroxycoumarin | 7.94e-05 | 13 | 152 | 3 | CID000122783 | |
| Drug | DFMO | 8.39e-05 | 155 | 152 | 7 | CID000003009 | |
| Drug | NSC350593 | 8.46e-05 | 269 | 152 | 9 | CID000004364 | |
| Drug | arsenic | 9.73e-05 | 274 | 152 | 9 | CID005359596 | |
| Drug | D-triiodothyronine | ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 ACTL6A GSTM1 BRD8 ATP2B2 G6PD ATP2B3 | 9.89e-05 | 409 | 152 | 11 | CID000000861 |
| Drug | kabiramide C | 1.01e-04 | 14 | 152 | 3 | CID005288658 | |
| Drug | Epi Lovastatin | RAP2A CYP11A1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 LMNB2 ACTL6A RAP2C | 1.02e-04 | 341 | 152 | 10 | CID000003962 |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.70e-10 | 8 | 149 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.70e-10 | 8 | 149 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.70e-10 | 8 | 149 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.70e-10 | 8 | 149 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 7.58e-10 | 10 | 149 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.58e-10 | 10 | 149 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | mitochondrial DNA measurement | 4.64e-05 | 328 | 149 | 9 | EFO_0006312 | |
| Disease | Colorectal Carcinoma | EVC2 KALRN SYNE1 APC2 ARFGEF1 LAMB3 LMNB2 ADAMTSL3 GSTM1 PTPRS ABCB11 DNAH8 DCLK1 | 6.06e-05 | 702 | 149 | 13 | C0009402 |
| Disease | Junctional epidermolysis bullosa | 7.57e-05 | 3 | 149 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 7.57e-05 | 3 | 149 | 2 | cv:C0079683 | |
| Disease | junctional epidermolysis bullosa Herlitz type (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0060737 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 7.57e-05 | 3 | 149 | 2 | 226700 | |
| Disease | Herlitz Disease | 1.51e-04 | 4 | 149 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.51e-04 | 4 | 149 | 2 | C0079297 | |
| Disease | Kartagener syndrome (is_implicated_in) | 1.51e-04 | 4 | 149 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 2.51e-04 | 5 | 149 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 2.51e-04 | 5 | 149 | 2 | C2608084 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 2.51e-04 | 5 | 149 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 2.51e-04 | 5 | 149 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 2.51e-04 | 5 | 149 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 2.51e-04 | 5 | 149 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 2.51e-04 | 5 | 149 | 2 | EFO_0800429 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 2.51e-04 | 5 | 149 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | SYNE1 NDUFB7 PTPRG CLEC17A RHOBTB2 PLCB1 DNAH8 DNAH9 ATP2B2 DCLK1 DNAH11 | 3.22e-04 | 619 | 149 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Junctional Epidermolysis Bullosa | 3.75e-04 | 6 | 149 | 2 | C0079301 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.75e-04 | 6 | 149 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | asthma, cardiovascular disease | 4.64e-04 | 30 | 149 | 3 | EFO_0000319, MONDO_0004979 | |
| Disease | Intellectual Disability | 4.67e-04 | 447 | 149 | 9 | C3714756 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 5.23e-04 | 7 | 149 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Global developmental delay | 5.87e-04 | 133 | 149 | 5 | C0557874 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 8.64e-04 | 37 | 149 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 8.91e-04 | 9 | 149 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.62e-03 | 12 | 149 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Primary Ciliary Dyskinesia | 1.74e-03 | 47 | 149 | 3 | C4551720 | |
| Disease | endometriosis | 1.82e-03 | 252 | 149 | 6 | EFO_0001065 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.90e-03 | 13 | 149 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | myocardial infarction | 2.07e-03 | 350 | 149 | 7 | EFO_0000612 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 2.21e-03 | 14 | 149 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | multiple myeloma, monoclonal gammopathy | 2.21e-03 | 14 | 149 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.21e-03 | 14 | 149 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Ciliopathies | 2.38e-03 | 110 | 149 | 4 | C4277690 | |
| Disease | Situs ambiguus | 2.55e-03 | 15 | 149 | 2 | C0266642 | |
| Disease | caffeine measurement | 2.55e-03 | 15 | 149 | 2 | EFO_0021177 | |
| Disease | prostate specific antigen measurement | 2.72e-03 | 188 | 149 | 5 | EFO_0004624 | |
| Disease | leukemia | 2.73e-03 | 55 | 149 | 3 | C0023418 | |
| Disease | Drug habituation | 2.80e-03 | 115 | 149 | 4 | C0013170 | |
| Disease | Drug abuse | 2.80e-03 | 115 | 149 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.80e-03 | 115 | 149 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.80e-03 | 115 | 149 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.80e-03 | 115 | 149 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.80e-03 | 115 | 149 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.80e-03 | 115 | 149 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.80e-03 | 115 | 149 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.80e-03 | 115 | 149 | 4 | C0029231 | |
| Disease | Substance abuse problem | 2.89e-03 | 116 | 149 | 4 | C0740858 | |
| Disease | neuroblastoma | 2.89e-03 | 116 | 149 | 4 | EFO_0000621 | |
| Disease | Chromosome Aberrations | 2.90e-03 | 16 | 149 | 2 | C0008625 | |
| Disease | Autosome Abnormalities | 2.90e-03 | 16 | 149 | 2 | C0004403 | |
| Disease | age at menarche | 3.31e-03 | 594 | 149 | 9 | EFO_0004703 | |
| Disease | Myeloid Leukemia | 3.67e-03 | 18 | 149 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.67e-03 | 18 | 149 | 2 | C0023466 | |
| Disease | event free survival time, urinary bladder cancer | 4.09e-03 | 19 | 149 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 4.99e-03 | 21 | 149 | 2 | EFO_0007908, EFO_0007938 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVDVFQVAKMINLMR | 1376 | P23470 | |
| LLQVNQAELMQLDME | 311 | Q96CN4 | |
| IQAVLEDHSQMRQME | 1226 | Q86US8 | |
| IDRNFQVSMLAVDEM | 311 | Q8NFU1 | |
| FMDQQITAVILNRME | 731 | Q96Q91 | |
| IVAMMVTNFQNIRKE | 336 | Q96P56 | |
| QEMLNHATQRVMEAE | 156 | O60239 | |
| MAVEMQRDVLEQIQQ | 796 | Q9H0E9 | |
| AQFLRDLMLMFQNAV | 1166 | Q9H0E9 | |
| ANREKMTQIMFETFN | 116 | P68133 | |
| NREKMTQIMFEAFNT | 116 | Q562R1 | |
| NEQIALVLMRLQEDM | 446 | Q5T8D3 | |
| NYILMQAQALEEMRR | 291 | Q8NFJ8 | |
| ATLTQMLNVIFARME | 196 | Q9Y6D6 | |
| MLNVIFARMENQALQ | 201 | Q9Y6D6 | |
| MTMFENVTRALARQL | 1 | Q96QA5 | |
| FITMQCRELFQEMNI | 201 | O96019 | |
| ANREKMTQIMFETFN | 116 | P62736 | |
| LTQMLNVIFTRMENQ | 186 | Q9Y6D5 | |
| DMAIRCIAQMVNSQA | 1201 | Q9Y6D5 | |
| LALVNSSNVRAMMQE | 371 | O75843 | |
| SSNVRAMMQELQAFL | 376 | O75843 | |
| MLQMQESTRLFEVAL | 1296 | Q96DT5 | |
| DAIADQMALFIQRMT | 211 | O95342 | |
| NREKMTQIMFETFNV | 116 | P63267 | |
| QQLMTELTDFMHIFR | 806 | Q96M86 | |
| RLAQNMAQMNDVILS | 176 | Q96PN6 | |
| IIMDDEFQLLQRNFM | 31 | Q9Y2Y0 | |
| LFTQRNMKAQEEMIS | 796 | O14578 | |
| TFVMMQLFNEINARK | 1001 | Q01814 | |
| FVMMQLFNEINARKI | 976 | Q16720 | |
| IDMVRNQAMADAFER | 1701 | Q8IZY2 | |
| DQMRANVINEIMSTE | 101 | O43307 | |
| TMVDELFAEIVRQMN | 151 | P10114 | |
| SMVDELFAEIVRQMN | 151 | Q9Y3L5 | |
| EMVQNLMVLRFANRI | 206 | P11413 | |
| VRMTENEENMQLAQA | 21 | Q9H306 | |
| CIDTVANMQLVRMYQ | 121 | Q8N468 | |
| DIEFQIRDMLMQFVT | 151 | Q05193 | |
| MVDFAQERQMLQALK | 146 | Q9BTV5 | |
| HLMVDFSQERQMLQT | 176 | Q9BXM9 | |
| TEMRDVMQQQLAEYQ | 361 | Q03252 | |
| LRFMQEMIELSSQQQ | 626 | Q9BZQ6 | |
| MMLLVDVDQRFSAVQ | 626 | O15075 | |
| RFTEMREMDLQVQNA | 21 | Q9NXR8 | |
| REMDLQVQNAMDQLE | 26 | Q9NXR8 | |
| MDQLEQRVSEFFMNA | 36 | Q9NXR8 | |
| AYRLMQEEEMNILIN | 296 | P54750 | |
| FRLMQDDEMNIFINL | 301 | Q01064 | |
| IRMFTDLNLVQNFQM | 576 | O76074 | |
| LNSMNIFLRQEIDRM | 4251 | Q96JB1 | |
| SMIMSNIQRIIQENE | 561 | Q5T1M5 | |
| TMERMEEALQVAINN | 996 | Q8IVU3 | |
| YNVLGAETVLNQMRM | 481 | Q1KMD3 | |
| ERKLAMNNMTFEVIQ | 816 | O60229 | |
| DQMEMLLERAQTEVF | 636 | Q86UK5 | |
| VMLERACDQNNSIMV | 711 | Q5S007 | |
| MKFQQVREQMEAEIA | 406 | Q86UP2 | |
| QVDTQQLMRVYGALM | 226 | Q9H223 | |
| DQNMLAVIDELMQAL | 156 | P29459 | |
| MLVDQVMSQRAISFA | 81 | Q8NH04 | |
| SMVREFVMQEAQQSD | 396 | Q5MIZ7 | |
| QVLMGRMESVFNQAI | 461 | Q96F07 | |
| NQFLARMQLSEIMER | 811 | P78316 | |
| LMMAFRDVTVQIANQ | 481 | Q9UPP2 | |
| RTLLQDMLTMQQNVY | 1096 | A2RRP1 | |
| ATQQEMMDAQLRLQL | 41 | P17568 | |
| VTLMRSQRNYMVQTE | 1621 | Q13332 | |
| ALSINEEMQRMLNQL | 396 | Q0D2I5 | |
| NCSFNIMDIVAQMRE | 376 | Q4JDL3 | |
| ARFEMVLDLMQQLQD | 246 | P40855 | |
| QEMQLLQVAAMNYRL | 426 | Q8IZJ4 | |
| ICNNSDIFQKEMLRM | 191 | Q7L622 | |
| HVETQFSMQMDLIRQ | 171 | O95996 | |
| FSMQMDLIRQQLEFE | 176 | O95996 | |
| VMADAFRIAFEQQLM | 321 | Q86Z20 | |
| VIMNMVQNKVFLRAI | 986 | Q14185 | |
| AMSMVQNRVFLRAIN | 991 | Q92608 | |
| DMMQQLFLDRLQTLT | 416 | Q8WTW3 | |
| MNVNEVISNRAIEML | 151 | P07954 | |
| VAQLNDVMDTMLERA | 221 | Q5T1B0 | |
| YVQMLDQIARQMIDF | 291 | Q5T1B0 | |
| IRAMAQQVFMLDTQC | 1661 | Q5TH69 | |
| QLLEMEARAAQMAQQ | 126 | P0CW27 | |
| EDHERILMQVMNLNV | 66 | A8MZ97 | |
| TQLEMEIQEAFLRFM | 556 | Q5VZ89 | |
| EMTIFLINMLENFRV | 471 | P05108 | |
| QILQMSYQDIRSEVM | 451 | Q96JA4 | |
| NSMVKSFFIRQMERV | 1751 | Q03164 | |
| DRRFQLQEVMMEFQG | 111 | Q13751 | |
| DQFMQQLQRMEALIS | 621 | Q13753 | |
| QMLDARHIEIQQMES | 1256 | Q9NYC9 | |
| MAAMEIFTAQQQEDI | 481 | Q9UNN5 | |
| RQQNIEENMTIAMEE | 211 | Q5TDH0 | |
| LEETINMFERNIVDM | 376 | Q9H069 | |
| QLEVQVMAAQEMELA | 6 | Q8IZT9 | |
| MMLINLVNADFEFQK | 16 | A0A1B0GVD1 | |
| MAQALSEEEFQRMQA | 1 | Q4V328 | |
| SELIQTRMMDQAINN | 296 | Q9UKT9 | |
| GRNQEHQVMFSMLEI | 146 | B7ZC32 | |
| RSEMENIFMLIEEFN | 1226 | Q8TE73 | |
| NQEIRNMQMISFAKD | 311 | Q9GZK3 | |
| IEFANMQQQREEDRM | 271 | Q8NEH6 | |
| AQDRFLIMAAEMEQS | 401 | Q8NHP6 | |
| LQDMLTNRQDYIQMI | 636 | A6NKG5 | |
| VLNEIQLRMLQNMAS | 396 | Q5T160 | |
| LEQLESQFVLMQQMR | 446 | O14607 | |
| EIEVDIQFMRNNMTA | 141 | Q6WKZ4 | |
| MVDDMLQENHQRVSI | 96 | Q9UI12 | |
| FQEVQRLLHLMNVEM | 156 | Q9BRC7 | |
| QVLVAYSMLQMVREQ | 271 | Q8IYX1 | |
| YSMLQMVREQVLQES | 276 | Q8IYX1 | |
| AQLMDCQNMLVEIEQ | 6121 | Q8NF91 | |
| NMEDVLAVKSFRMQN | 416 | Q8N0V4 | |
| LEDTVQNVNLQMSRM | 1771 | Q8N4C6 | |
| MKANFLQNMIEDRTE | 1061 | O95486 | |
| ENRISMEFMLQVFNK | 461 | Q6P1X5 | |
| RVDILENQTMDNHMQ | 96 | P09488 | |
| QRACLNLTMVVMVNS | 36 | Q14916 | |
| MNSILERMCADVLQQ | 666 | O75448 | |
| MENLQTEIQEMEFLQ | 256 | Q8IYU8 | |
| EVFDLRMMVANILNN | 456 | Q9BYZ6 | |
| VENAFQLMDEQMARE | 236 | Q5JR12 | |
| VAELTQQMFDARNTM | 286 | Q9H4B7 | |
| LTEAMLQNMEAEQQR | 281 | A8MXQ7 | |
| DEMVIEYVGQNIRQM | 1591 | O15047 | |
| EYVGQNIRQMVADMR | 1596 | O15047 | |
| QLVMTFQHFMREEIQ | 146 | Q9H7B4 | |
| QAEFFIKNMNVEEML | 161 | O43556 | |
| MRIFTVAQMDDNSIQ | 876 | Q9UP95 | |
| ANREKMTQIMFETFN | 116 | P68032 | |
| DMAIVNNENNRMSIE | 556 | Q8TBZ0 | |
| FQMQLLQRSLGIMQT | 901 | Q86XI2 | |
| QELMEELRMLSFQQM | 196 | Q6ZS10 | |
| EAIDMRENMQNAIVS | 896 | Q15111 | |
| NVMQETIRNLDCIEM | 31 | P16415 | |
| DQNMQRMAVAIISIL | 461 | Q9C0D3 | |
| RQTLFEDSFQQIMNM | 521 | O00308 | |
| VTAEMFRHMQNSEII | 131 | Q8N3U4 | |
| DQIQDSELVRMMFNL | 1971 | Q15413 | |
| MFNLLEMDIEQVSQL | 201 | Q99962 | |
| MDRAQALMDNIDTFI | 201 | O14787 | |
| AIQDMFPNMDQEVIR | 236 | Q9H0E2 | |
| NQVKFSELTVDMFRM | 286 | Q8N9R8 | |
| SFASEQSIQRLIMMN | 111 | Q8IYF3 | |
| RVFLQLRVAVAMMDQ | 371 | Q9NY15 | |
| NMQNAEIIRKMTEEF | 141 | Q8WVM7 | |
| TVDQMMDFINLKQRD | 241 | Q9NQ66 | |
| MVALNFQTMDLAMQI | 621 | Q9NQ66 | |
| LMQAMRFAVEEINND | 71 | Q8TE23 | |
| QMANERISMQNLEAL | 556 | Q9BZW7 | |
| VEELEQLTQQLMQDM | 356 | Q15942 | |
| VRRYSVDQENNMMVL | 231 | Q9NQZ5 | |
| VDQENNMMVLVSRAV | 236 | Q9NQZ5 | |
| MDRQTVSMAINEVFN | 191 | Q9UH65 | |
| MLNNFRVDNALSTEM | 281 | A6NLI5 | |
| MAQITEALQSNMRFC | 261 | Q9NX45 | |
| IIQELSVNMDAQMRF | 836 | Q5T4S7 | |
| VLDMLNFLMDAIQTN | 1811 | Q5T4S7 | |
| EMRENFQKQLQEIMS | 1066 | Q92547 | |
| ELQQFMKDQVRAAMT | 2256 | Q68DK2 | |
| NMLCVVVNDMEQLRL | 696 | Q70J99 | |
| NFEEDFMRQQRTINM | 231 | Q8N6V9 | |
| VMVQITAENMDSLRQ | 1226 | O95405 | |
| MDTAQFDELIRNMSQ | 1091 | P82987 | |
| TAKAENMIQLQFRME | 561 | P20592 | |
| LLDQVTMEDFMRNLQ | 16 | B0I1T2 |